27
Aug
2024

Sinopep-Allsino Biopharmaceutical Co., Ltd.

Exhibitor at CPHI Korea 2024 stand N33
About Us

Sinopep-Allsino Biopharmaceutical Co Ltd. (Stock Code: 688076) is a leading, innovation-driven company specializing in the development and manufacturing of peptides, oligonucleotides and small molecules. With years experience and expertise, Sinopep provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers CDMO/CRO services, we have 3 RND centers and 2 manufacturing sites(EDQM&FDA approved sites), most of our drug substances have been approved in the US, EU, UK & CN mark...

  • CN
  • 2018
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
API Producer
Contract Manufacturer
Intermediates Manufacturer
Contact info
Event information
CPHI Korea 2024
  • 27 Aug 2024 - 29 Aug 2024
  • COEX, Seoul, Korea
  • Visit us at stand N33

Products Featured at CPHI Korea 2024